Wave Life Sciences, Duchenne muscular dystrophy
Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug
Wave Life Sciences Ltd. (NASDAQ:WVE) revealed interim data from the ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne muscular dystrophy (DMD) patients amenable to exon 53 skipping. DMD is a genetic disease that causes progressive muscle weakness and degeneration caused by a mutation in the dystrophin gene.
Wave’s result is in line with the data that supported accelerated approval of NS Pharma’s exon 53 DMD drug Viltepso. NS ...
The Muscular Dystrophy Association (MDA) held its first-ever Clays for a Cure event on Friday, Sept. 20. Check out the photos ...
Pratteln, Switzerland, September 24, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that Swissmedic, the Swiss Agency for Therapeutic Products, has accepted for review the marketing ...
Discover Avidity Biosciences' groundbreaking patent for treating facioscapulohumeral muscular dystrophy (FSHD) using a novel polynucleic acid conjugate targeting the DUX4 gene.
Brodie Pankhurst suffers from Duchenne muscular dystrophy, which progressively weakens his muscles. The cruel illness has ...
Six-year-old Cooper Wood was diagnosed with Duchenne muscular dystrophy earlier this year. When his parents applied for a one ...
If you notice traffic backing up and firefighters out at an intersection on Friday and Saturday, don’t worry — it’s all for a ...
CAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company ...
The Cambridge Professional Fire Fighters’ Association held their annual Muscular Dystrophy Boot Drive on Saturday.
KCBS Radio San Francisco on MSN6d
As Prescribed: How treatment for muscular dystrophy is continuing to advanceA quarter of a million Americans are living with muscular dystrophy or a related neuromuscular disorder. It's the reason ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback